cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Ptc Therapeutics Inc
2 own
8 watching
Current Price
$25.29
$-0.39
(-1.52%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
2,177.05M
52-Week High
52-Week High
59.84000
52-Week Low
52-Week Low
17.53000
Average Volume
Average Volume
0.68M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization2,177.05M
icon52-Week High59.84000
icon52-Week Low17.53000
iconAverage Volume0.68M
iconDividend Yield--
iconP/E Ratio--
What does the Ptc Therapeutics Inc do?
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of orally administered, small molecule drugs that target post-transcriptional control processes. The company's lead product is Translarna (ataluren), for the treatment of nonsense mutation Duchenne muscular dystrophy in ambulatory patients; and which is in phase III clinical trials to treat cystic fibrosis caused by nonsense mutations. It also develops Translarna, which is in Phase II clinical trials for the treatment of mucopolysaccharidosis type I caused by nonsense mutation, nonsense mutation aniridia, and nonsense mutation Dravet syndrome/CDKL5; and RG7916 that is in Phase I clinical trials to treat spinal muscular atrophy. In addition, the company's product candidate in cancer stem cell program include PTC596, an orally bioavailable and potent small molecule, which has completed phase I clinical trials that targets tumor stem cell populations by reducing the activity and amount of a protein called BMI1. PTC Therapeutics, Inc. has collaborations with F. Hoffman-La Roche Ltd and Hoffman-La Roche Inc., and the Spinal Muscular Atrophy Foundation to develop and commercialize compounds identified under its spinal muscular atrophy sponsored research program; and research collaboration with Massachusetts General Hospital for the treatment of rare genetic disorders resulting from pre-mRNA. The company was founded in 1998 and is headquartered in South Plainfield, New Jersey.
Read More
How much money does Ptc Therapeutics Inc make?
News & Events about Ptc Therapeutics Inc.
Globe Newswire
9 months ago
NEW YORK, July 02, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of PTC Therapeutics, Inc. ( PTC or the Company ) (NASDAQ: PTCT). Such investors are...
Globe Newswire
9 months ago
NEW YORK, June 25, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of PTC Therapeutics, Inc. (PTC or the Company) (NASDAQ:PTCT). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980. The investigation ...
PR Newswire
9 months ago
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PTC Therapeutics, Inc. - PTCT SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PTC Therapeutics, Inc. - PTCT PR Newswire NEW YORK, June 23, 2023 NEW YORK, June 23, 2023...
Ticker Report
11 months ago
PTC Therapeutics (NASDAQ:PTCT Get Rating) had its target price hoisted by Credit Suisse Group from $48.00 to $51.00 in a research report sent to investors on Friday, The Fly reports. Several other brokerages have also commented on PTCT. Raymond James dropped their price target on shares of ...
Zolmax
11 months ago
PTC Therapeutics (NASDAQ:PTCT Get Rating) had its price target boosted by Citigroup from $61.00 to $67.00 in a research report sent to investors on Friday, The Fly reports. PTCT has been the subject of a number of other reports. Credit Suisse Group restated a neutral rating and set a $48.00 price ...
Frequently Asked Questions
Frequently Asked Questions
What is Ptc Therapeutics Inc share price today?
plus_minus_icon
Can Indians buy Ptc Therapeutics Inc shares?
plus_minus_icon
How can I buy Ptc Therapeutics Inc shares from India?
plus_minus_icon
Can Fractional shares of Ptc Therapeutics Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Ptc Therapeutics Inc stocks?
plus_minus_icon
What is today’s traded volume of Ptc Therapeutics Inc?
plus_minus_icon
What is today’s market capitalisation of Ptc Therapeutics Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Ptc Therapeutics Inc?
plus_minus_icon
What percentage is Ptc Therapeutics Inc down from its 52-Week High?
plus_minus_icon
What percentage is Ptc Therapeutics Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$25.29
$-0.39
(-1.52%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00